Institutions · Entity Annotation Prototype (beta)

2articles mentioning institutions

2institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: Second Xiangya Hospital ×

Second Xiangya Hospital

This institution is selected. Its supporting articles are shown below.

Second Xiangya Hospital2

Articles mentioning Second Xiangya Hospital

2 articles · page 1 of 1

Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial

lupusscimed · abstract · 2026-05-20 · 1 matching annotations

81.8%

Central South University Second Xiangya Hospital rivaroxaban aspirin systemic lupus erythematosus antiphospholipid syndrome SLE

…dical Research Ethics Committee of the Second Xiangya Hospital, Central South University (approval number: LYEC2025-K0180) and will be conducted in acco…

Comparison of remimazolam–flumazenil versus propofol on delayed emergence from anaesthesia in major spine surgery: protocol for a multicentre, single-blinded, randomised controlled trial

bmjopen · abstract · 2025-08-08 · 1 matching annotations

87.7%

Central South University Second Xiangya Hospital flumazenil propofol Remimazolam besylate remimazolam DE IBM Corp.